Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension

OBJECTIVE: Pulmonary arterial hypertension (PAH) is a debilitating disease associated with progressive vascular remodeling of distal pulmonary arteries leading to elevation of pulmonary artery pressure, right ventricular hypertrophy, and death. Although presenting high levels of DNA damage that norm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arterioscler Thromb Vasc Biol
Main Authors: Bourgeois, Alice, Bonnet, Sébastien, Breuils-Bonnet, Sandra, Habbout, Karima, Paradis, Renée, Tremblay, Eve, Lampron, Marie-Claude, Orcholski, Mark E., Potus, Francois, Bertero, Thomas, Peterlini, Thibaut, Chan, Stephen Y., Norris., Karen A, Paulin, Roxane, Provencher, Steeve, Boucherat, Olivier
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6727643/
https://ncbi.nlm.nih.gov/pubmed/31092016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.119.312537
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares